StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was $10.23B, up 45.3% from the year before. Over ten years it grew 13.7% a year on average. The highest annual figure on record is $10.23B in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.23B+45.3%
FY2024Dec 31, 2024$7.04B+18.1%
FY2023Dec 31, 2023$5.96B+81.1%
FY2022Dec 31, 2022$3.29B+2835.7%
FY2021Dec 31, 2021$112.00M-96.5%
FY2020Dec 31, 2020$3.20B+139.4%
FY2019Dec 31, 2019$1.34B-38.1%
FY2018Dec 31, 2018$2.16B-28.2%
FY2017Dec 31, 2017$3.00B-14.2%
FY2016Dec 31, 2016$3.50B+23.9%
FY2015Dec 31, 2015$2.83B–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.51B+596.4%
Q2 FY2025Jun 30, 2025$2.45B+345.5%
Q2 FY2024Jun 30, 2024$1.93B+154.9%
Q2 FY2023Jun 30, 2023$1.82B+1298.5%
Q2 FY2022Jun 30, 2022$360.00M+2.9%
Q2 FY2021Jun 30, 2021$550.00M+15.3%
Q2 FY2020Jun 30, 2020$756.00M–
Q2 FY2019Jun 30, 2019$130.00M–
Q2 FY2018Jun 30, 2018$350.00M–
Q2 FY2017Jun 30, 2017$477.00M–

More AstraZeneca figures

See a number that looks wrong?